A federal appeals court today upheld a ruling against Argentum Medical in its patent infringement battle against Noble Biomaterials. The Federal Circuit Appeals Court denied Argentum’s bid without comment today in a per curiam decision, according to court documents. It’s the most recent development in a longstanding feud between Argentum and Noble over Noble’s SilverSeal anti-microbial bandages, which Argentum claimed infringed on 1 of their patents. Argentum sued Noble […]
Argentum Medical
MassDevice.com +3 | Argentum sues IP firm, Recall: St. Jude’s Riata, Senators probe med-tech on recalls
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Argentum sues IP firm, lawyer over lapsed patent | Legal News
Argentum Medical is suing its former intellectual property law firm after it lost a patent infringement suit it filed against Noble Biomaterials.
Occlutech CEO: St. Jude’s patent suit against me “amazing and quite shocking” | Legal News
A patent spat between St. Jude Medical (NYSE:STJ) and Occlutech GmbH that morphed into a personal lawsuit against Occlutech CEO Tor Peters was dismissed by a German court, prompting Peters to call the suit "amazing and quite shocking."
St. Jude inherited the case, involving intravascular occlusion devices, after it acquired AGA Medical for more than $1 billion last year.
Exactech rep slips prison in kickbacks scheme | Legal Roundup
A former sales rep for Exactech Inc. avoided prison but landed five years’ probation and $56,000 in fines after pleading guilty to setting up a kickbacks scheme to encourage orthopedic surgeons to use the company’s hip and knee implants.
Judge Garrett Brown of the U.S. District Court for New Jersey handed down the sentence to Douglas Donofrio, the former New York-area sales director for the Gainesville, Fla.-based company. Donofrio pleaded guilty to running the scheme between 2002 and 2008.
